title: Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.
authors.forename: S
authors.initials: S
authors.lastname: Boonen
authors.forename: D
authors.initials: D
authors.lastname: Vanderschueren
authors.forename: K
authors.initials: K
authors.lastname: Venken
authors.forename: P
authors.initials: P
authors.lastname: Geusens
authors.forename: P
authors.initials: P
authors.lastname: Haentjens
authors.forename: S
authors.initials: S
authors.lastname: Mohan
authors.forename: D J
authors.initials: DJ
authors.lastname: Baylink
authors.forename: R
authors.initials: R
authors.lastname: Bouillon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density / Q000502:physiology; D001861:Bone Regeneration / Q000502:physiology; D015536:Down-Regulation / Q000502:physiology; D005260:Female; D005265:Femoral Neck Fractures / Q000503:physiopathology*; D006620:Hip Fractures / Q000503:physiopathology*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D018975:Insulin-Like Growth Factor Binding Protein 5 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000502:physiology; D007335:Insulin-Like Growth Factor II / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000502:physiology; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology; D012016:Reference Values; D012307:Risk Factors
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D018975:Insulin-Like Growth Factor Binding Protein 5; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II